Research Article

AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells

Table 1

Top ten genesb.
(a) Clofibrate

Gene IDGene nameFold change

GANAB*Glucosidase, alpha; neutral AB+3.8
ATF6BActivating transcription factor 6 beta+2.8
SETD5SET domain containing 5+2.6
NFAT5Nuclear factor of activated T cells 5, tonicity-responsive+2.5
DLSTDihydrolipoamide S-succinyltransferase (E2 component of 2-oxoglutarate complex)+2.3
IL6STInterleukin 6 signal transducer (gp130, oncostatin M receptor)+2.1
HNRNPA0Heterogeneous nuclear ribonucleoprotein A0+2.0
MEX3DMex-3 homolog D (C. elegans)+1.6
CTSZCathepsin Z+1.5

STIP 1Stress-induced phosphoprotein 1−3.1
CLASP 1Cytoplasmic linker-associated protein 1−3.1
MACF 1Microtubule-actin cross-linking factor 1−2.9
COPACoatomer protein complex, subunit alpha−2.7
HNRNPA1Heterogeneous nuclear ribonucleoprotein A1−2.6
SPSB2SplA/ryanodine receptor domain and SOCS box containing 2−2.3
TSR1TSR1, 20S rRNA accumulation, homolog (S. cerevisiae)−2.3
VIL1*Villin 1−2.3
CDH1Cadherin 1, type 1, E-cadherin (epithelial)−2.2
CRTAPCartilage-associated protein−2.2

(b) AS601245

Gene IDGene nameFold change

CYP1A1Cytochrome P450, family 1, subfamily A, polypeptide 1+5.3
AP3D1Adaptor-related protein complex 3, delta 1 subunit+3.6
NFAT5Nuclear factor of activated T cells 5, tonicity-responsive+3.1
BMP2KBone morphogenetic protein 2 inducible kinase+2.9
DLSTDihydrolipoamide S-succinyltransferase (E2 component of 2-oxoglutarate complex)+2.8
IL6STInterleukin 6 signal transducer (gp130, oncostatin M receptor)+2.8
FAM76BFamily with sequence similarity 76, member B+2.4
MGAMAX gene associated+2.4
THRAP3Thyroid hormone receptor-associated protein 3+2.4
GANABGlucosidase, alpha; neutral AB+2.3

RPS27ARibosomal protein S27a−4.2
HNRNPA1Heterogeneous nuclear ribonucleoprotein A1−4.1
WDR33WD repeat domain 33−3.9
EPN1Epsin 1−3.7
KLC2Kinesin light chain 2−3.6
STIP1Stress-induced phosphoprotein 1−3.6
SEPT9Septin 9−3.4
TFDP1Transcription factor Dp-1−3.1
LAD1Ladinin 1−3.1
CABIN 1Calcineurin-binding protein 1−3.1

(c) Clofibrate + AS601245

Gene IDGene nameFold change

CYP1A1Cytochrome P450, family 1, subfamily A, polypeptide 1+7.5
IL6STInterleukin 6 signal transducer (gp130, oncostatin M receptor)+6.4
AP3D1Adaptor-related protein complex 3, delta 1 subunit+5.1
WASF2WAS protein family, member 2+4.1
VAPBVAMP- (vesicle-associated membrane-protein-)associated protein B and C+3.9
NFAT5*Nuclear factor of activated T cells 5, tonicity-responsive+3.8
THRAThyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian)+3.6
GANAB*Glucosidase, alpha; neutral AB+3.6
BDP1B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB+3.4
SMARCC1SWI/SNF related, matrix associated, actin-dependent regulator of chromatin, subfamily c, member 1+3.2

TRUB1TruB pseudouridine (psi) synthase homolog 1 (E. coli)−4.4
HNRNPA1Heterogeneous nuclear ribonucleoprotein A1−3.9
SLC39A14Solute carrier family 39 (zinc transporter), member 14−3.6
NXT2Nuclear transport factor-2-like export factor 2−3.4
MALAT1Metastasis-associated lung adenocarcinoma transcript 1 (nonprotein coding)−3.2
LARP5La ribonucleoprotein domain family, member 5−3.0
FGBFibrinogen beta chain−2.8
ACTC1Actin, alpha, cardiac muscle 1−2.8
TFRCTransferrin receptor (p90, CD71)−2.8
RPS27ARibosomal protein S27a−2.7

bThe top ten genes upregulated and downregulated the most by 5 μM Clofibrate (Table 1(a)), 0.1 μM AS601245 (Table 1(b)), and combined treatment (Table 1(c)) with respect to DMSO-treated Caco-2 cells at 24 h.